SIS
HRMY icon

Sound Income Strategies’s Harmony Biosciences HRMY Stock Holding History

Sound Income Strategies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-113
Closed -$3.16K – 1315
2026
Q1 		$3.16K Hold
113
– – ﹤0.01% 2017
2025
Q4 		$4.09K Buy
+113
New +$3.71K ﹤0.01% 1898

Other funds holding HRMY

CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SCM
Sidoxia Capital Management Newport Beach, California $136M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Sound Income Strategies's HRMY Position: Q2 2026 in Review

Sound Income Strategies sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 113 shares — an estimated $3.16K sold.

Sound Income Strategies first reported a position in HRMY in Q4 2025 and held it in 2 quarters. The position peaked at $4.09K in Q4 2025. 63 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Sound Income Strategies reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 113 Harmony Biosciences shares in Q2 2026, an estimated $3.16K.
  • Sound Income Strategies first reported a position in Harmony Biosciences in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's Harmony Biosciences position peaked at $4.09K in Q4 2025.
  • 63 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.